InvestorsHub Logo
Followers 22
Posts 3689
Boards Moderated 0
Alias Born 07/20/2006

Re: marthambles post# 13083

Tuesday, 02/17/2015 12:39:04 PM

Tuesday, February 17, 2015 12:39:04 PM

Post# of 20689

If the IVIG program pans out, it would be huge.


True - but what is extremely significant, as has been stated -

Based on extensive characterization of the mechanism of action of IVIg, both in animal models and in humans, we rationally designed a series of recombinant drug candidates with the potential to deliver improved therapeutic benefit compared to IVIg. These agents are termed Selective Immunodulators of Fc Receptors (SIF’s), and they selectively modulate the activity of members of the Fcg receptor family. In cell and animal models of immune-complex-mediated autoimmunity, SIF’s display up to 500-fold greater potency than IVIg.